Sanofi FY 2012 - Interview with CEO Chris Viehbacher

Thu Feb 7, 2013 1:45am EST

* Reuters is not responsible for the content in this press release.

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130207:nBw066836a

PARIS--(Business Wire)--
Sanofi, a global and diversified healthcare leader, reports 2012 results. CEO
Chris Viehbacher comments on 2012 results and outlook for 2013. 

Click to watch the video:http://bit.ly/XkZjhU

Topics covered in the interview include: 

- 2012 Results
- Genzyme
- Emerging Markets
- Diabetes franchise
- R&D Pipeline
- Animal Health
- Capital Allocation
- Cost savings
- 2013 Guidance 

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients` needs. Sanofi has core
strengths in the field of healthcare with seven growth platforms: diabetes
solutions, human vaccines, innovative drugs, consumer healthcare, emerging
markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT:
SAN) and in New York (NYSE: SNY). 

Company website: www.sanofi.com

Sanofi
Investor Relations:
S├ębastien Martel, +33 1 53 77 45 45
IR@sanofi.com
or
Media Relations:
+33 1 53 77 45 02
MR@sanofi.com

Copyright Business Wire 2013

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.